A citation-based method for searching scientific literature

Alexander M M Eggermont, Vanna Chiarion-Sileni, Jean-Jacques Grob, Reinhard Dummer, Jedd D Wolchok, Henrik Schmidt, Omid Hamid, Caroline Robert, Paolo A Ascierto, Jon M Richards, Céleste Lebbé, Virginia Ferraresi, Michael Smylie, Jeffrey S Weber, Michele Maio, Lars Bastholt, Laurent Mortier, Luc Thomas, Saad Tahir, Axel Hauschild, Jessica C Hassel, F Stephen Hodi, Corina Taitt, Veerle de Pril, Gaetan de Schaetzen, Stefan Suciu, Alessandro Testori. N Engl J Med 2016
Times Cited: 815



Daniel Y Wang, Joe-Elie Salem, Justine V Cohen, Sunandana Chandra, Christian Menzer, Fei Ye, Shilin Zhao, Satya Das, Kathryn E Beckermann, Lisa Ha, W Kimryn Rathmell, Kristin K Ancell, Justin M Balko, Caitlin Bowman, Elizabeth J Davis, David D Chism, Leora Horn, Georgina V Long, Matteo S Carlino, Benedicte Lebrun-Vignes, Zeynep Eroglu, Jessica C Hassel, Alexander M Menzies, Jeffrey A Sosman, Ryan J Sullivan, Javid J Moslehi, Douglas B Johnson. JAMA Oncol 2018
Times Cited: 873




List of shared articles



Times cited


Risk assessment, diagnosis, and treatment of cancer treatment-related adrenal insufficiency.
Annabelle G Hayes, R Louise Rushworth, David J Torpy. Expert Rev Endocrinol Metab 2022
1


Immune Checkpoint Inhibitors in the Treatment of Cancer.
Wissam Zam, Lina Ali. Curr Rev Clin Exp Pharmacol 2022
10

Immune Checkpoint Blockade and Skin Toxicity Pathogenesis.
Barbara Ma, Niroshana Anandasabapathy. J Invest Dermatol 2022
1

Potential Role of CXCL13/CXCR5 Signaling in Immune Checkpoint Inhibitor Treatment in Cancer.
Ching-Hung Hsieh, Cheng-Zhe Jian, Liang-In Lin, Guan-Sian Low, Ping-Yun Ou, Chiun Hsu, Da-Liang Ou. Cancers (Basel) 2022
1

Incidence of hepatotoxicity associated with addition of immune checkpoint blockade to systemic solid tumor therapy: a meta-analysis of phase 3 randomized controlled trials.
Yu Fujiwara, Nobuyuki Horita, Matthew Harrington, Ho Namkoong, Hirotaka Miyashita, Matthew D Galsky. Cancer Immunol Immunother 2022
0


Pembrolizumab in the adjuvant treatment of melanoma: efficacy and safety.
Caroline A Nebhan, Douglas B Johnson. Expert Rev Anticancer Ther 2021
0